Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy
Clinical trial NCT00801177 · COMPLETED
Trial details
- NCT number
- NCT00801177
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2007-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.